When used together, non-contrast simple CT and CT perfusion have higher prediction rates
Computed tomography – both simple and advanced – can accurately predict which stroke patients will most likely benefit from endovascular thrombectomy to remove large cerebral clots. And, the predictive capability increases when both CT profiles are used together.
Results from the multi-center study, conducted by investigators at The University of Texas Health Science Center at Houston (UTHealth), were published recently in Annals of Neurology.
Ischemic stroke, caused by an artery blockage, is the most common form of stroke. In most cases, endovascular thrombectomy – threading a mechanical device through the artery – can be an effective treatment that improves clinical outcomes up to 24 hours from onset.
Imaging is required to determine where the clot is located and whether the patient is a good thrombectomy candidate, meaning they have a smaller area of brain tissue death. According to Amrou Sarraj, M.D., lead author and associate professor of neurology at UTHealth’s McGovern Medical School, different imaging techniques are currently used to make this decision, but little is known about how they correlate with each other.
Both non-contrast simple CT and CT with injected contrast dye (CT perfusion) are routinely used to pinpoint the clot and the surrounding areas of cellular death. Most hospitals have access to simple CT, but CT perfusion is frequently only available at advanced stroke centers.
Investigators reviewed both the CT and CT perfusion results of 361 enrolled patients. Most had favorable imaging results on both types of scans, indicating they were strong candidates for endovascular thrombectomy. Additionally, those patients had significantly higher chances of receiving endovascular therapy, and 58 percent had better recovery rates after 90 days.
In cases where the imaging modalities disagreed, Sarraj said, functional and safety outcomes were still acceptable. Among patients, 38 percent reached functional independence, a higher amount than patients who didn’t receive thrombectomy. However, patients who had unfavorable CT perfusion results, but favorable simple CT ones, did experience more post-stroke symptomatic brain tissue hemorrhage and death. Patients with unfavorable results for both modalities had very poor outcomes.
An additional, ongoing trial is focused on assessing the safety and efficacy of thrombectomy procedures in patients with unfavorable profiles on one or both imaging modalities.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.